Prostate Medicament Using Drone Brood for Hypertensive Patients

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing treatments for adenoma and prostatitis, such as Leveton, are limited for hypertensive patients due to contraindications, restricting their use, especially among elderly individuals who often experience these conditions concurrently with hypertension.

Innovation Solution

A medicament comprising pollen, ascorbic acid, vitamin E, and drone brood, with specific excipients, replaces Leuzea to enhance therapeutic action without side effects, utilizing drone brood's enzymatic and hormonal properties to stimulate androgen formation and reduce inflammatory processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If Leuzea is used in the medicament composition, then the therapeutic action for adenoma and prostatitis is enhanced, but the medicament becomes contraindicated for hypertensive patients

Engineering Contradiction:

Improvetherapeutic actionVSAvoidapplicability to hypertensive patients

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent removes Leuzea from the medicament composition specifically for hypertensive patients, extracting the problematic ingredient while retaining the beneficial components (pollen, ascorbic acid, vitamin E, drone brood) that provide therapeutic action without causing harmful effects on arterial tension

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates different formulations of the medicament tailored to specific patient groups: one formulation includes Leuzea for non-hypertensive patients to maximize therapeutic effect, while another formulation excludes Leuzea for hypertensive patients to avoid adverse effects, thereby adapting the composition quality to local patient needs

Inventive Principle:

Principle #3Local quality

2Reliability

If the medicament includes multiple active ingredients for comprehensive treatment, then the therapeutic effectiveness is improved, but the complexity of the composition increases

Engineering Contradiction:

Improvetherapeutic effectivenessVSAvoidcomposition complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent combines multiple active ingredients (pollen, ascorbic acid, vitamin E, drone brood, and optionally Leuzea) into a single integrated medicament formulation, merging their complementary therapeutic actions to achieve comprehensive treatment of adenoma and prostatitis while maintaining a unified dosage form

Inventive Principle:

Principle #5Merging (Combining)

Solution Approach 2:

The patent creates a composite medicament formulation where different biological and chemical substances are combined in specific proportions to achieve synergistic therapeutic effects, utilizing the complementary properties of each ingredient to treat multiple aspects of the disease simultaneously

Inventive Principle:

Principle #40Composite materials

Data Source

PatentEP2510931B1Medicament for preventing and treating adenoma of the prostate gland and prostatitis

Publication Date: 2017.12.13 OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOSTJU PARAFARM

AI summary

The invention pertains to the field of the chemical-pharmaceutical industry, and relates to the production of a therapeutic medium for preventing and treating adenomas and prostatitis and for increasing potency. The therapeutic medium contains the following ingredients: flower pollen, bee brood, ascorbic acid, vitamin E and carriers. This medium can be used by aged persons having an increased arterial pressure.